386 related articles for article (PubMed ID: 18068264)
1. Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996.
Schneider JS; Moore DH; Mendelsohn ML
J Am Acad Dermatol; 2008 May; 58(5):741-9. PubMed ID: 18068264
[TBL] [Abstract][Full Text] [Related]
2. Cancer incidence rates among Lawrence Livermore National Laboratory (LLNL) employees: 1974-1997.
Whorton MD; Moore DN; Seward JP; Noonan KA; Mendelsohn ML
Am J Ind Med; 2004 Jan; 45(1):24-33. PubMed ID: 14691966
[TBL] [Abstract][Full Text] [Related]
3. Early diagnosis of cutaneous malignant melanoma at Lawrence Livermore National Laboratory.
Schneider JS; Moore DH; Sagebiel RW
Arch Dermatol; 1990 Jun; 126(6):767-9. PubMed ID: 2346320
[TBL] [Abstract][Full Text] [Related]
4. Medical surveillance for melanoma at the Lawrence Livermore National Laboratory.
Wald PH; Schneider JS
Occup Med; 1990; 5(3):607-16. PubMed ID: 2218804
[TBL] [Abstract][Full Text] [Related]
5. What motivates men age > or =50 years to participate in a screening program for melanoma?
Janda M; Youl PH; Lowe JB; Baade PD; Elwood M; Ring IT; Aitken JF
Cancer; 2006 Aug; 107(4):815-23. PubMed ID: 16832794
[TBL] [Abstract][Full Text] [Related]
6. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
Lasithiotakis KG; Leiter U; Gorkievicz R; Eigentler T; Breuninger H; Metzler G; Strobel W; Garbe C
Cancer; 2006 Sep; 107(6):1331-9. PubMed ID: 16909413
[TBL] [Abstract][Full Text] [Related]
7. Strategies for improving melanoma education and screening for men age >or= 50 years: findings from the American Academy of Dermatological National Skin Cancer Sreening Program.
Geller AC; Sober AJ; Zhang Z; Brooks DR; Miller DR; Halpern A; Gilchrest BA
Cancer; 2002 Oct; 95(7):1554-61. PubMed ID: 12237925
[TBL] [Abstract][Full Text] [Related]
8. Early detection of melanoma: an educational campaign in Padova, Italy.
Rossi CR; Vecchiato A; Bezze G; Mastrangelo G; Montesco MC; Mocellin S; Meneghetti G; Mazzoleni F; Peserico A; Nitti D; Lise M
Melanoma Res; 2000 Apr; 10(2):181-7. PubMed ID: 10803719
[TBL] [Abstract][Full Text] [Related]
9. Early detection of thick melanomas in the United States: beware of the nodular subtype.
Demierre MF; Chung C; Miller DR; Geller AC
Arch Dermatol; 2005 Jun; 141(6):745-50. PubMed ID: 15967921
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for melanoma incidence in prospective follow-up. The importance of atypical (dysplastic) nevi.
Schneider JS; Moore DH; Sagebiel RW
Arch Dermatol; 1994 Aug; 130(8):1002-7. PubMed ID: 8053695
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous melanoma mortality starting to change: a study of trends in Northern Ireland.
Montella A; Gavin A; Middleton R; Autier P; Boniol M
Eur J Cancer; 2009 Sep; 45(13):2360-6. PubMed ID: 19375307
[TBL] [Abstract][Full Text] [Related]
12. Increased melanoma risk in Parkinson disease: a prospective clinicopathological study.
Bertoni JM; Arlette JP; Fernandez HH; Fitzer-Attas C; Frei K; Hassan MN; Isaacson SH; Lew MF; Molho E; Ondo WG; Phillips TJ; Singer C; Sutton JP; Wolf JE;
Arch Neurol; 2010 Mar; 67(3):347-52. PubMed ID: 20212233
[TBL] [Abstract][Full Text] [Related]
13. Sun exposure and mortality from melanoma.
Berwick M; Armstrong BK; Ben-Porat L; Fine J; Kricker A; Eberle C; Barnhill R
J Natl Cancer Inst; 2005 Feb; 97(3):195-9. PubMed ID: 15687362
[TBL] [Abstract][Full Text] [Related]
14. Who attends skin cancer clinics within a randomized melanoma screening program?
Youl PH; Janda M; Elwood M; Lowe JB; Ring IT; Aitken JF
Cancer Detect Prev; 2006; 30(1):44-51. PubMed ID: 16457967
[TBL] [Abstract][Full Text] [Related]
15. The melanoma epidemic debate: some evidence for a real phenomenon from Tuscany, Italy.
Chellini E; Crocetti E; Carli P; Martini A; Giovannetti L
Melanoma Res; 2007 Apr; 17(2):129-30. PubMed ID: 17496788
[TBL] [Abstract][Full Text] [Related]
16. The relation between mortality from malignant melanoma and early detection in the Cancer Research Campaign Mole Watcher Study.
Melia J; Moss S; Coleman D; Frost T; Graham-Brown R; Hunter JA; Marsden RA; du Vivier A; Warin AP; White J; Whitehead SM; Wroughton MA
Br J Cancer; 2001 Sep; 85(6):803-7. PubMed ID: 11556828
[TBL] [Abstract][Full Text] [Related]
17. Cancer incidence among employees of the Lawrence Livermore National Laboratory, 1969-1980.
Reynolds P; Austin DF
West J Med; 1985 Feb; 142(2):214-8. PubMed ID: 4013251
[TBL] [Abstract][Full Text] [Related]
18. Ability to self-detect malignant melanoma decreases with age.
Trolle L; Henrik-Nielsen R; Gniadecki R
Clin Exp Dermatol; 2011 Jul; 36(5):499-501. PubMed ID: 21418284
[TBL] [Abstract][Full Text] [Related]
19. Thin primary cutaneous melanomas: associated detection patterns, lesion characteristics, and patient characteristics.
Schwartz JL; Wang TS; Hamilton TA; Lowe L; Sondak VK; Johnson TM
Cancer; 2002 Oct; 95(7):1562-8. PubMed ID: 12237926
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the usefulness of self-reported risk factors in a skin cancer screening program.
Williams HA; Fritschi L; Beauchamp C; Katris P
Melanoma Res; 2006 Aug; 16(4):341-5. PubMed ID: 16845330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
